ACAM-FLU-A: Phase I data

In a double-blind, placebo-controlled, U.S. Phase I trial in adult volunteers, ACAM-FLU-A was well tolerated and immunogenic when given alone or with aluminum hydroxide or QS-21 Stimulon adjuvant. In ...